Pular para conteúdo

Talassemia Beta Intermediária e Menor\_

Cuidados Médicos

Quelação de Ferro

Iron out for nontransfused thalassemia. (abre nova janela)

Marks PW.

Fonte‎: Blood 2012;120(5):928-9.

Indexado‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (abre nova janela)

Iron overload in β-thalassemia intermedia: an emerging concern. (abre nova janela)

Musallam KM, Cappellini MD, Taher AT.

Fonte‎: Curr Opin Hematol 2013;20(3):187-92.

Indexado‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (abre nova janela)

Suplementos Alimentares e Outras Terapias de Apoio\_

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (abre nova janela)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Fonte‎: Blood 2012;120(7):1531-2.

Indexado‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (abre nova janela)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (abre nova janela)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Fonte‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indexado‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (abre nova janela)

Therapeutic roles of curcumin: lessons learned from clinical trials. (abre nova janela)

Gupta SC, Patchva S, Aggarwal BB.

Fonte‎: AAPS J 2013;15(1):195-218.

Indexado‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (abre nova janela)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (abre nova janela)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Fonte‎: J Med Assoc Thai 2012;95(1):29-36.

Indexado‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (abre nova janela)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (abre nova janela)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Fonte‎: Am J Hematol 2013;88(6):503-6.

Indexado‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (abre nova janela)